Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

12

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

176655888

Full Text :

https://doi.org/10.1200/JCO.23.01547